Throwing up negatives and positives will do nothing to expedite the desired results from this company. It may make the stock more volatile and that seem to be the motive here. The company is moving along and has been doing what it says it will been doing, notwithstanding anyone else's opinion here - because opinions are like.....well, you know the saying. Its ALL speculation - but remember, most health-related/biotech firms that go from the OTC to NASDAQ have no actual product and no revenues. They move up exchanges to get more sophisticated eyeballs and attract big money to fund their business models and the development of their products. If you want to invest in fundamentals, wait to see if this company uplifts and performs, because saying you invest in fundamentals at this level, is a complete joke. Investments are made on either what if's, or whats done. Here, we are right in the middle. Forecasting is a huge part of any public company, so to say the CEO's forecasts mean nothing, then you completely missed the boat, or, are just too early to participate.
More money is invested at much higher levels into companies that can make a difference in healthcare, whether it is a new drug formulary, or a new medical device, and that those companies products address huge health and monetary issues. IMHO, CVS, McKesson, the safe product, are all but stepping stones to a much bigger game. I realize this, its a shame that so many people here are short-sighted.
I can tell this is shorted big time, no matter what analysis you want to put into play, painting on 1 trade on a $1.40 spread, flipping, shorting report sites are not credible, no revenues report yet - all of what the company is doing takes time - and while some of you want to distract from the companies progress, it doesn't change the fact that the company HAS and continues to make progress.
